| scholarly article | Q13442814 |
| P2093 | author name string | Cheryl A Conover | |
| Sean C Harrington | |||
| Laurie K Bale | |||
| P2860 | cites work | The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A | Q22009032 |
| Molecular regulation of the IGF-binding protein-4 protease system in human fibroblasts: identification of a novel inducible inhibitor | Q28207689 | ||
| Differential response of vascular smooth muscle cells to oxidized LDL in mouse strains with different atherosclerosis susceptibility | Q30439207 | ||
| Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells | Q33905168 | ||
| Insulin-like growth factor-1 enhances inflammatory responses in endothelial cells: role of Gab1 and MEKK3 in TNF-alpha-induced c-Jun and NF-kappaB activation and adhesion molecule expression | Q34133390 | ||
| Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels | Q34275284 | ||
| Does the coronary risk factor low density lipoprotein alter growth and signaling in vascular smooth muscle cells? | Q34956804 | ||
| Bone morphogenetic protein-2 induces proinflammatory endothelial phenotype | Q35087897 | ||
| Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells | Q35553734 | ||
| Diabetic microangiopathy: IGFBP control endothelial cell growth by a common mechanism in spite of their species specificity and tissue peculiarity | Q36620111 | ||
| Pregnancy-associated plasma protein-A (PAPP-A): a local regulator of IGF bioavailability through cleavage of IGFBPs | Q36705609 | ||
| Insulin, insulin-like growth factors, and vascular endothelium | Q39488618 | ||
| Surface association of pregnancy-associated plasma protein-A accounts for its colocalization with activated macrophages | Q40220343 | ||
| Stress-activated signaling pathways mediate the stimulation of pregnancy-associated plasma protein-A expression in cultured human fibroblasts. | Q40354884 | ||
| Determinants of atherosclerosis susceptibility in the C3H and C57BL/6 mouse model: evidence for involvement of endothelial cells but not blood cells or cholesterol metabolism | Q41737918 | ||
| Evidence that the interaction between insulin-like growth factor (IGF)-II and IGF binding protein (IGFBP)-4 is essential for the action of the IGF-II-dependent IGFBP-4 protease | Q41748050 | ||
| Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-alpha. | Q41988723 | ||
| Cytokine stimulation of pregnancy-associated plasma protein A expression in human coronary artery smooth muscle cells: inhibition by resveratrol. | Q42487658 | ||
| Pregnancy-associated plasma protein A as a marker of acute coronary syndromes | Q43756514 | ||
| Transforming growth factor-beta regulation of the insulin-like growth factor binding protein-4 protease system in cultured human osteoblasts | Q44484952 | ||
| A redox-sensitive pathway mediates oxidized LDL-induced downregulation of insulin-like growth factor-1 receptor | Q46417743 | ||
| Regulation of bone morphogenetic protein-2 expression in endothelial cells: role of nuclear factor-kappaB activation by tumor necrosis factor-alpha, H2O2, and high intravascular pressure | Q46455351 | ||
| Characterisation of receptors for IGF-I and insulin; evidence for hybrid insulin/IGF-I receptor in human coronary artery endothelial cells. | Q53604844 | ||
| Tumor Necrosis Factor-α Regulates Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3 Expression in Vascular Smooth Muscle | Q57908156 | ||
| Differential effects of low density lipoproteins on IGF-1 and IGF-1R expression in vascular smooth muscle cells | Q57908167 | ||
| Pregnancy-Associated Plasma Protein-A Is Markedly Expressed by Monocyte-Macrophage Cells in Vulnerable and Ruptured Carotid Atherosclerotic Plaques | Q58492179 | ||
| Stimulatory effects of insulin and insulin-like growth factor I on migration and tube formation by vascular endothelial cells | Q67539831 | ||
| Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes | Q72223364 | ||
| Insulin-like growth factor binding protein-4 protease produced by smooth muscle cells increases in the coronary artery after angioplasty | Q73570841 | ||
| Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse | Q74582629 | ||
| Native and oxidized low density lipoproteins oppositely modulate the effects of insulin-like growth factor I on VSMC | Q75310650 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 213-220 | |
| P577 | publication date | 2007-10-23 | |
| P1433 | published in | Growth Hormone & I G F Research | Q15766227 |
| P1476 | title | Differential regulation of pregnancy associated plasma protein-A in human coronary artery endothelial cells and smooth muscle cells | |
| P478 | volume | 18 |
| Q37775591 | Altered levels of insulin-like growth factor binding protein proteases in preeclampsia and intrauterine growth restriction |
| Q46429830 | Association of E-selectin gene polymorphism and serum PAPP-A with carotid atherosclerosis in end-stage renal disease |
| Q42326410 | CRP and TNF-α induce PAPP-A expression in human peripheral blood mononuclear cells |
| Q83585649 | High positive predictive value of PAPP-A for acute coronary syndrome diagnosis in heparin-naïve patients |
| Q35691367 | Influence of concomitant heparin administration on pregnancy-associated plasma protein-A levels in acute coronary syndrome with ST segment elevation |
| Q35947007 | Key questions and answers about pregnancy-associated plasma protein-A. |
| Q33519234 | Longitudinal trends in the association of metabolic syndrome with 550 k single-nucleotide polymorphisms in the Framingham Heart Study. |
| Q90093908 | PAPP-A and the IGF system in atherosclerosis: what's up, what's down? |
| Q34617964 | PAPP-A: a new anti-aging target? |
| Q37678178 | PAPP-A: a promising therapeutic target for healthy longevity. |
| Q33923940 | Preferential expression of PAPPA in human preadipocytes from omental fat |
| Q57825165 | Pregnancy-Associated Plasma Protein A as an Independent Mortality Predictor in Long-Term Hemodialysis Patients |
| Q89687367 | Pregnancy-associated plasma protein A as a predictor of all-cause mortality and cardiovascular events in patients with chronic kidney disease: a meta-analysis of prospective studies |
| Q36984041 | Pregnancy-associated plasma protein A predicts adverse vascular events in patients with coronary heart disease: a systematic review and meta-analysis |
| Q37739378 | Pregnancy-associated plasma protein-A is a stronger predictor for adverse cardiovascular outcomes after acute coronary syndrome in type-2 diabetes mellitus |
| Q45243439 | Pregnancy-associated plasma protein-A is related to gender and to adipocytokine levels: results of the Health Survey of Catalonia |
| Q36395088 | Role of PAPP-A in aging and age-related disease |
| Q39397667 | The impact of inherited thrombophilia on first trimester combined aneuploidy screening test parameters |
| Q35690633 | The role of PAPP-A in the IGF system: location, location, location. |
| Q34112115 | Tissue-specific changes in pregnancy associated plasma protein-A expression with age in mice |
| Q34092815 | Transgenic overexpression of pregnancy-associated plasma protein-A in murine arterial smooth muscle accelerates atherosclerotic lesion development |
Search more.